Menopause weight gain is biology, not willpower

If the diet that always worked has stopped working in your 40s or 50s, you are not failing. Your body has changed. UK-licensed GLP-1 treatment, prescribed by a registered pharmacist, can help.

Why the menopause changes the rules

Around the perimenopause and menopause, four things shift at once. Together they make weight harder to lose and easier to gain, even when nothing about your effort has changed.

Oestrogen falls

As oestrogen drops, the body stores more fat around the middle rather than the hips and thighs. The shape of weight gain changes, and so does how stubborn it is.

Muscle declines

Muscle mass falls with age, and muscle burns more energy at rest than fat. Less muscle means a slower metabolism, so the same meals now go further than they used to.

Sleep suffers

Night sweats and broken sleep raise the hunger hormones the next day. Poor sleep drives cravings for quick, high-sugar food, often at the hardest times to resist.

Stress and cortisol rise

Busy work and family life, on top of hormonal change, keep cortisol high. Raised cortisol encourages the body to hold on to fat around the abdomen.

This is not a willpower problem. It is a biology problem. That difference matters, because it is why so many women feel they are failing when they are not.

How GLP-1 treatment can help

GLP-1 medicines such as Mounjaro and Wegovy are prescription-only treatments that support weight loss in suitable people. They are not a quick fix, and they are not right for everyone. Like all medicines, they can cause side effects, so they are prescribed and supervised by a clinician who checks the treatment is safe and appropriate for you before you start.

The effect most women describe is the same. The constant background hunger quietens down. The thinking about the next snack, the second helpings and the late-night picking, often called food noise, eases off. When hunger is no longer fighting you all day, sensible eating stops feeling like a battle.

In clinical trials at 72 weeks, Mounjaro produced an average 22.5% reduction in body weight and Wegovy an average of 20.7%. Individual results vary depending on your starting weight, your dose, your lifestyle and how long you stay on treatment.

The medicine does not do the work on its own. What it does is make the rest possible, which matters most when your biology has stopped cooperating.

Treatments suitable during the menopause

Suitability is decided by our prescribing pharmacist after a clinical assessment, not by a form. Generally, GLP-1 treatment is considered for adults with a BMI over 30, or over 27 with a weight-related health condition.

Most effective

Mounjaro

Tirzepatide

From £169.99/month

Average 22.5% body weight loss at 72 weeks
Dual-action GLP-1 and GIP receptor agonist
Weekly injection

Heart health benefits

Wegovy

Semaglutide

From £89.99/month

Average 20.7% body weight loss at 72 weeks
GLP-1 receptor agonist
Weekly injection

What helps alongside the medicine

Women who do best treat the medicine as one part of the plan. These four habits protect muscle and metabolism, which matter even more during the menopause.

Prioritise protein

Protein at every meal protects muscle and keeps you full for longer. This matters more during the menopause, when muscle is already under pressure.

Keep moving

Not punishing workouts. Daily walks and simple strength work two or three times a week hold on to muscle and protect your metabolism.

Drink more water

Easy to forget, and it helps with both appetite and energy through the day.

Stay supervised

Prescriptions are reviewed every 3 months. Regular check-ins mean your dose and progress are monitored and any side effects are managed early.

Jennifer's story

Jennifer is 43. Like many women her age, she found the perimenopause changed everything about how her body held weight. She lost it, and she explains how. Her experience is her own, and results vary from person to person.

Menopause and weight loss: your questions

Does GLP-1 treatment work during the menopause?

GLP-1 medicines can support weight loss in suitable people, including women going through the perimenopause and menopause. Suitability is decided by our prescribing pharmacist after a clinical assessment of your health, history and current medications.

Why is it so much harder to lose weight in my 40s and 50s?

Falling oestrogen shifts fat storage to the middle, muscle mass declines and slows the metabolism, disrupted sleep raises hunger hormones, and higher cortisol encourages fat storage. These changes happen together, which is why the same effort no longer produces the same result. It is biology, not a lack of willpower.

Can I take GLP-1 treatment alongside HRT?

Many women manage the menopause with HRT and ask about weight loss treatment at the same time. Tell our prescribing pharmacist about all your current medicines, including HRT, during your consultation. They will review everything together and advise whether treatment is safe and suitable for you.

How much weight could I expect to lose?

In clinical trials at 72 weeks, the average reduction was 22.5% of body weight on Mounjaro and 20.7% on Wegovy. These are averages from trials, not a promise. Steady, gradual weight loss over months is more typical, and more likely to last, than rapid drops. Individual results vary.

Do I have to commit to a subscription?

No. There is no subscription. You pay for each month as you go and can stop at any time. Your prescription is reviewed every 3 months to confirm the treatment is working for you and remains appropriate.

What are the common side effects?

Common side effects of GLP-1 medicines include nausea, constipation and reduced appetite. These usually improve within a few weeks as your body adjusts. Our aftercare includes weekly guidance on managing side effects. If you experience concerning symptoms, contact our team at [email protected].

Want to read more about weight loss and GLP-1 medication?

Read our Weight Loss Health Guide

Find out if treatment is right for you

Check your eligibility in under three minutes. A qualified prescriber reviews your answers personally. No GP appointment needed.